Practice-Changing Viral Hepatitis Data From AASLD 2022

November 4-8, 2022; Washington, DC
Listen to expert insights from Nancy Reau, MD, on practice-changing viral hepatitis data from AASLD 2022, including HBV therapeutics in the pipeline, HCV management strategies, HDV screening and care linkage, fatty liver disease in patients with viral hepatitis, and the role of statins in patients with liver disease.
Nancy Reau, MD
Released: December 6, 2022

In this episode, Nancy Reau, MD, shares her thoughts on the most practice-changing viral hepatitis data from AASLD 2022, including:

  • Novel therapeutics for HBV
  • HCV management strategies
  • HDV screening and linkage to care
  • Fatty liver disease in persons with viral hepatitis
  • Use of statins to decrease morbidity and mortality in persons with liver disease

Information on this Educational Activity


Nancy Reau, MD

Professor of Medicine
Section of Hepatology
Associate Director, Solid Organ Transplantation
Richard B. Capps Chair of Hepatology
Rush University Medical Center
Chicago, Illinois

Nancy Reau, MD: consultant/advisor: AbbVie, Antios, Arbutus, Gilead Sciences, Intercept, Salix; researcher: AbbVie, Gilead Sciences, Intercept.

Program Medium

This program has been made available online.


Provided by Clinical Care Options, LLC.

Contact Clinical Care Options

For customer support please email:

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
AbbVie Inc.
Gilead Sciences, Inc.

Related Content

Downloadable slideset from Coleman I. Smith, MD, on the recommendations and screening guidelines for HDV, provided by Clinical Care Options (CCO)

Coleman I. Smith, MD Released: February 6, 2023

Drs. Coleman Smith and Lydia Tang: how to screen for hepatitis D virus and strategies to increase HDV testing rates, from Clinical Care Options (CCO)

Coleman I. Smith, MD person default Lydia Tang, MBChB Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: February 6, 2023 Expired: February 5, 2024

Use this guide to learn more about screening and identifying HDV in your patients with HBV, from Clinical Care Options (CCO)

Nancy Reau, MD Released: January 31, 2023

Matuto mula kay Dr Nancy Reau kung bakit maaaring gusto naming hamunin ang mga kasalukuyang alituntunin sa pagsusuri ng HDV, mula sa Clinical Care Options (Mga Opsyon sa Klinikal na Pangangalaga) (CCO)

Nancy Reau, MD Released: January 26, 2023

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings